Merck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference (Transcript)

Merck & Co., Inc. (NYSE:MRK) BofA Securities 2025 Healthcare Conference May 14, 2025 1:40 PM ET Company Participants Jannie Oosthuizen - President Peter Dannenbaum - Senior Vice President, Investor Relations Marjorie Green - SVP, Head of Oncology Clinical Development Conference Call Participants Tim Anderson - Bank of America Tim Anderson Thanks for joining us for this, meeting. I'm Tim Anderson, the U.S. large-cap pharma and biotech analyst at Bank of America. We have the pleasure of speaking with Merck to ...